13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding. 2007

Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
Service of Gastroenterology and Hepatology, La Princesa University Hospital, Universidad Autónoma, Madrid, Spain. gisbert@meditex.es

OBJECTIVE To evaluate the accuracy of (13)C-urea breath test (UBT) to detect Helicobacter pylori infection in patients hospitalized with peptic ulcer bleeding and treated with proton pump inhibitors (PPIs). METHODS Patients hospitalized with peptic ulcer bleeding, and treated with omeprazole, had a first UBT performed the day after resuming oral feeding. Patients with a negative UBT during hospitalization underwent a repeated UBT 15 days after stopping PPIs. RESULTS The first UBT during hospitalization was positive in 86% of 131 patients. Time between admission and performance of the test was longer in patients with negative versus positive UBT (5.2 +/- 0.7 versus 4.3 +/- 0.5 days; p < .001). The repeated UBT became positive in 15 of 18 (83%) patients with a negative first UBT. In the multivariate analysis, the only variable associated with a negative first UBT was the time elapsed between admission and performance of the test (odds ratio = 6.6; 95%CI = 2.9-15.1). CONCLUSIONS Most H. pylori-positive patients with ulcer bleeding have a positive UBT (performed just after resuming oral feeding) despite previous treatment with high-dose PPIs. Nevertheless, to preclude false-negative results due to PPI therapy, the UBT should be performed as early as possible. If the infection cannot be demonstrated with this first UBT, H. pylori still needs to be definitively excluded with a second UBT performed after stopping PPIs.

UI MeSH Term Description Entries
D010437 Peptic Ulcer Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). Gastroduodenal Ulcer,Marginal Ulcer,Gastroduodenal Ulcers,Marginal Ulcers,Peptic Ulcers,Ulcer, Gastroduodenal,Ulcer, Marginal,Ulcer, Peptic,Ulcers, Gastroduodenal,Ulcers, Marginal,Ulcers, Peptic
D001944 Breath Tests Any tests done on exhaled air. Breathalyzer Tests,Breath Test,Breathalyzer Test,Test, Breath,Test, Breathalyzer,Tests, Breath,Tests, Breathalyzer
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter

Related Publications

Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
January 2009, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
January 2013, European review for medical and pharmacological sciences,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
May 1991, Gut,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
March 1993, Zhonghua nei ke za zhi,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
February 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
March 2005, World journal of gastroenterology,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
January 1996, The American journal of gastroenterology,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
July 1999, Gut,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
January 2004, Digestive diseases and sciences,
Javier P Gisbert, and Carlos Esteban, and Isabel Jimenez, and Ricardo Moreno-Otero
January 1998, Journal of gastroenterology,
Copied contents to your clipboard!